Keywords: strong, ph, iii, data, bioenvision, evoltra, new

Strong Ph III data for Bioenvision's Evoltra

Article | 02 October 2006

Print This

New York, USA-based Bioenvision says that the latest results from an ongoing European study of Evoltra (clofarabine) in pediatric acute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in